PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic JournalOpen Access

Frontiers in Neurology

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Frontiers in Neurology has 1 tracked paper indexed in Blossom (2022) from 7 authors, most often covering LSD and MDMA, across Headache Disorders (Cluster & Migraine) and Chronic Pain.

Published Papers

Open Accessmeta

Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature

This retrospective series of 13 patients and review of 24 case reports found that HPPD commonly causes visual snow, floaters, palinopsia, photophobia and nyctalopia despite normal ophthalmic and neurological investigations, producing a phenotype that overlaps substantially with Visual Snow Syndrome. The authors argue DSM‑5 diagnostic criteria should be expanded to include these symptoms, that VSS patients be screened for prior hallucinogen use, and that controlled studies compare primary and secondary VSS to clarify pathophysiology and treatment.

Published
May 6, 2022
Journal
Frontiers in Neurology
Authors
Van Der Walt, A., Ford, H., Fraser, C. L., Solly, E., Clough, M., Fielding, J., White, O.

Quick Facts

Papers Indexed
1
h-Index
118
Open Access
Yes
Publisher
Frontiers Media
Country
Switzerland
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.